Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Mold Infections”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Large-scale testing (Phase 3)Ended earlyNCT00836875
What this trial is testing

Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children

Who this might be right for
Invasive Aspergillosis
Pfizer 31
Large-scale testing (Phase 3)Looking for participantsNCT06925321
What this trial is testing

Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

Who this might be right for
Invasive Mold Infections
Basilea Pharmaceutica 234
Large-scale testing (Phase 3)Study completedNCT00634049
What this trial is testing

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Who this might be right for
AspergillosisInvasive Fungal Infections
Astellas Pharma Inc 149
Post-approval studies (Phase 4)Study completedNCT05630976
What this trial is testing

Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi

Who this might be right for
Invasive Fungal Disease
Pfizer 70
Not applicableStudy completedNCT03066011
What this trial is testing

Registry of Patients Treated With Systemic Mold-Active Triazoles

Who this might be right for
Invasive Fungal Infection
Astellas Pharma Global Development, Inc. 2,015
Large-scale testing (Phase 3)Study completedNCT04368559
What this trial is testing

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

Who this might be right for
CandidemiaMycosesFungal Infection+7 more
Mundipharma Research Limited 602
Testing effectiveness (Phase 2)Ended earlyNCT04240886
What this trial is testing

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds

Who this might be right for
Invasive Fungal Infections
Basilea Pharmaceutica 21
Not applicableLooking for participantsNCT01386437
What this trial is testing

Natural History of Individuals With Immune System Problems That Lead to Fungal Infections

Who this might be right for
Chronic Mucocutaneous CandidiasisInvasive AspergillosisCARD9+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Large-scale testing (Phase 3)Study completedNCT00412893
What this trial is testing

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

Who this might be right for
AspergillosisInvasive Fungal Infection
Astellas Pharma Inc 527
Early research (Phase 1)Looking for participantsNCT07704333
What this trial is testing

Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections

Who this might be right for
AspergillosMucormyeDimorphic+3 more
National Institutes of Health Clinical Center (CC) 100
Not applicableAvailableNCT06433128
What this trial is testing

Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections

Who this might be right for
Invasive Fungal Infections
Basilea Pharmaceutica
Early research (Phase 1)Not Yet RecruitingNCT07454122
What this trial is testing

CD5CAR-NK Cells for Refractory Invasive Mold Disease

Who this might be right for
Fungal Infection
Fundacion Clinic per a la Recerca Biomédica 10
Not applicableLooking for participantsNCT06285188
What this trial is testing

Immunomonitoring of Mold Invasive Infections

Who this might be right for
Invasive Fungal DiseaseMold Invasive Fungal Infection: Aspergillus, Mucorales, Fusarium, Scedosporium
Assistance Publique - Hôpitaux de Paris 20
Not applicableStudy completedNCT05774990
What this trial is testing

Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment

Who this might be right for
Leukemia, Myeloid, AcuteAcute Lymphoblastic Leukemia
University of Southern Denmark 621
Testing effectiveness (Phase 2)Looking for participantsNCT07215273
What this trial is testing

Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy

Who this might be right for
Invasive Mould Infection
Elion Therapeutics, Inc. 60
Not applicableStudy completedNCT02683642
What this trial is testing

Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and Outcome

Who this might be right for
Mycoses
Fungal Infection Study Forum 420
Not applicableStudy completedNCT02714504
What this trial is testing

Anti-mold Azole in the Prophylaxis for Invasive Fusariosis

Who this might be right for
FusariosisOnychomycosis
Universidade Federal do Rio de Janeiro 239
Post-approval studies (Phase 4)Ended earlyNCT00620074
What this trial is testing

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

Who this might be right for
Aspergillosis
Pfizer 6
Not applicableLooking for participantsNCT03827694
What this trial is testing

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

Who this might be right for
Pulmonary Invasive Fungal InfectionsPulmonary Invasive Aspergillosis
Arkansas Children's Hospital Research Institute 400
Post-approval studies (Phase 4)Study completedNCT01416025
What this trial is testing

A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing

Who this might be right for
Fungal Infection
Johns Hopkins University 29
Next Page